Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» remdesivir
remdesivir
Physicians criticize remdesivir distribution process
Beckers Hospital Review
Thu, 05/7/20 - 10:53 am
physicians
Gilead Sciences
COVID-19
remdesivir
From Gilead To AstraZeneca, Investors Should Watch These Biotech Giants Right Now
Motley Fool
Thu, 05/7/20 - 10:46 am
FDA
drug approvals
Gilead Sciences
remdesivir
AstraZeneca
Merck
Lynparza
Clovis Oncology
Rubraca
Bristol-Myers Squibb
Opdivo
Yervoy
After donation to the U.S., Gilead outlines plans to distribute COVID-19 drug worldwide
BioPharma Dive
Thu, 05/7/20 - 12:24 am
Gilead Sciences
pandemic
remdesivir
COVID-19
Here’s What Politicians Often Get Wrong About Remdesivir, Gilead’s Coronavirus Treatment
Forbes
Mon, 05/4/20 - 10:32 pm
Gilead Sciences
remdesivir
politicians
First doses of Gilead’s COVID-19 drug remdesivir to arrive at US hospitals
Pharmaforum
Mon, 05/4/20 - 10:30 am
Gilead Sciences
remdesivir
pandemic
COVID-19
Entire Stockpile Of Coronavirus Treatment Remdesivir Donated To Government, Says CEO
Forbes
Sun, 05/3/20 - 08:10 pm
Gilead Sciences
remdesivir
Daniel O'Day
pandemic
COVID-19
federal government
FDA Authorizes Gilead's Remdesivir for COVID-19
Motley Fool
Sat, 05/2/20 - 11:35 pm
Gilead Sciences
FDA
COVID-19
remdesivir
Emergency Use Authorization
How Gilead's coronavirus drug breakthrough is setting the tone for other potential treatments
Yahoo Finance
Sat, 05/2/20 - 11:19 pm
Gilead Sciences
remdesivir
COVID-19
pandemic
3 Big Stories in Gilead Sciences' Q1 Results
Motley Fool
Fri, 05/1/20 - 11:04 am
earnings
Gilead Sciences
remdesivir
COVID-19
Doctors anticipate patient requests for experimental remdesivir before all the evidence comes in
Stat
Thu, 04/30/20 - 10:46 pm
physicians
Gilead Sciences
remdesivir
COVID-19
After NIH trial, EMA begins rolling review for remdesivir, setting up potential authorizations in US and Europe
Endpoints
Thu, 04/30/20 - 10:43 pm
Gilead Sciences
remdesivir
COVID-19
EMA
NIH
FDA
Europe
Gilead’s Antiviral Remdesivir Had A Good Day - But It’s Still Not Clear How Effective It Is Against COVID-19
Forbes
Wed, 04/29/20 - 10:58 pm
Gilead Sciences
remdesivir
clinical trials
COVID-19
antivirals
Gilead CEO: We’re going to make sure that access is not an issue with remdesivir
Stat
Wed, 04/29/20 - 10:54 pm
Gilead Sciences
Daniel O'Day
Pharma CEOs
remdesivir
COVID-19
pandemic
access
Gilead says critical study of Covid-19 drug shows patients are responding to treatment
Stat
Wed, 04/29/20 - 10:58 am
Gilead Sciences
remdesivir
clinical trials
COVID-19
The world wants answers on Gilead’s Covid-19 drug. Experts worry next studies may increase uncertainty
Stat
Tue, 04/28/20 - 11:02 am
Gilead Sciences
remdesivir
COVID-19
pandemic
Gilead's COVID-19 hopeful remdesivir may get swift Japanese approval: report
Fierce Biotech
Mon, 04/27/20 - 09:40 am
Japan
Gilead Sciences
remdesivir
COVID-19
One leak good, two leaks bad for Gilead
EP Vantage
Fri, 04/24/20 - 10:50 am
Gilead Sciences
remdesivir
data leaks
China
COVID-19
coronaviruses
Did Gilead's remdesivir flop a Chinese trial? Analysts beg to differ
Fierce Biotech
Thu, 04/23/20 - 09:12 pm
Gilead Sciences
remdesivir
COVID-19
China
pandemic
clinical trials
Report: Congressman wants SEC investigation into Gilead Covid-19 data leak
MedCity News
Tue, 04/21/20 - 12:13 pm
legal
SEC
Gilead Sciences
remdesivir
NASDAQ
COVID-19
There's More to Gilead Sciences' Remdesivir Data Than Meets the Eye
Motley Fool
Tue, 04/21/20 - 12:10 am
Gilead Sciences
remdesivir
COVID-19
pandemic
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »